Somaxon (SOMX) Rips Premarket Following Silenor Collaboration
Tweet
Share
E-mailGet Alerts SOMX Hot Sheet
Join SI Premium – FREE
Somaxon (Nasdaq: SOMX) shares are ripping higher pre-market, after announcing a collaboration with Paladin to commercialize Silenor in Canada, South Amiercan and Africa.
Shares are up 13 percent.
Shares are up 13 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Ionis Pharma's therapy to treat rare genetic disorder
- Alumis SLE trial fails primary endpoints; subgroup data guides Phase 3
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
